J. Jardine

发表

Proof of principle for epitope-focused vaccine design

David Baker, Eric Stevens, Man Chen, 2014, Nature.

Rational immunogen design to target specific germline B cell receptors

David Nemazee, Oleksandr Kalyuzhniy, Skye MacPherson, 2012, Retrovirology.

Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows

D. Burton, I. Wilson, A. Ward, 2017, Nature.

HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen

Joseph G. Jardine, Oleksandr Kalyuzhniy, Yumiko Adachi, 2016, Science.

Broadening a SARS-CoV-1 neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution

D. Burton, I. Wilson, B. Briney, 2021, bioRxiv.

Vaccine monitoring shows that focused immunization with SARS-CoV-2 receptor-binding domain provides a better neutralizing antibody response than full-length spike protein

J. Jardine, S. Paludan, F. Öberg, 2021 .

One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

Paul J. Steiner, Timothy A. Whitehead, J. Jardine, 2021, Cell Reports.

HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway

T. Ndung’u, A. Sigal, A. Leslie, 2022, bioRxiv.

A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs

D. Burton, D. Nemazee, R. Fitzgerald, 2021, The Journal of Immunology.

Deep Generative Design of Epitope-Specific Binding Proteins by Latent Conformation Optimization

Raphael R. Eguchi, Christian A. Choe, Michael D. Ward, 2022, bioRxiv.

Structural basis of a shared antibody response to SARS-CoV-2

D. Burton, I. Wilson, N. Wu, 2020, Science.

Structural basis of a public antibody response to SARS-CoV-2

D. Burton, I. Wilson, N. Wu, 2020, bioRxiv.

Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model

D. Burton, B. Briney, D. Nemazee, 2020, bioRxiv.

SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.

J. Jardine, K. Iversen, M. Loftager, 2020, Journal of immunology.

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individuals

J. Jardine, K. Iversen, M. Loftager, 2020, medRxiv.

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

D. Burton, I. Wilson, B. Briney, 2020, Science.

SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain

J. Jardine, S. Paludan, F. Öberg, 2021, The Journal of Immunology.

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies

David Nemazee, Joseph G. Jardine, Oleksandr Kalyuzhniy, 2016, Cell.

Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design

D. Burton, I. Wilson, W. Schief, 2016, PLoS pathogens.

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways

Timothy A. Whitehead, D. Burton, D. Nemazee, 2022, bioRxiv.

Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice

Daniel W. Kulp, L. Stamatatos, John P. Moore, 2015, Cell.

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies

L. Stamatatos, A. West, A. McGuire, 2013, The Journal of experimental medicine.

Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen

David Nemazee, Joseph G. Jardine, Oleksandr Kalyuzhniy, 2015, Science.

Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice

Daniel W. Kulp, D. Burton, A. Bradley, 2016, Science.

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

Lisa E. Gralinski, Yana Safonova, D. Burton, 2023, Immunity.

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease

Lisa E. Gralinski, Yana Safonova, D. Burton, 2022, bioRxiv.

Anti-HIV B Cell Lines as Candidate Vaccine Biosensors

J. Mascola, J. Binley, R. Wyatt, 2012, The Journal of Immunology.

One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

Paul J. Steiner, Timothy A. Whitehead, J. Jardine, 2021, bioRxiv.

A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans.

D. Burton, I. Wilson, Chi‐Huey Wong, 2016, Immunity.

Rapid cGMP manufacturing of COVID‐19 monoclonal antibody using stable CHO cell pools

D. Burton, M. Feinberg, J. Jardine, 2021, Biotechnology and bioengineering.

Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design

D. Burton, I. Wilson, W. Schief, 2016, PLoS pathogens.

Engineering SARS-CoV-2 neutralizing antibodies for increased 1 potency and reduced viral escape 2 AUTHORS

Timothy A. Whitehead, D. Burton, D. Nemazee, 2022 .

Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins

D. Burton, Po-Ssu Huang, H. Turner, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice

Daniel W. Kulp, L. Stamatatos, John P. Moore, 2015, Cell.

Rational immunogen design to target specific germline B cell receptors

L. Stamatatos, A. McGuire, D. Nemazee, 2012, Retrovirology.

Diverse competitor B cell responses to a germline-targeting priming immunogen in human Ig loci transgenic mice

Daniel W. Kulp, J. Diedrich, W. Schief, 2024, bioRxiv.

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

Lisa E. Gralinski, Yana Safonova, D. Burton, 2023, Immunity.

Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution

D. Burton, Collin Joyce, D. Nemazee, 2023, Science Signaling.

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways

Timothy A. Whitehead, D. Burton, D. Nemazee, 2022, bioRxiv.

Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins

J. Jardine, R. Stanfield, D. Sok, 2024, Science Translational Medicine.